Brown Advisory Securities’s Aralez Pharmaceuticals Inc. ARLZ Stock Holding History

Brown Advisory Securities’s Portfolio ARLZ Stock Details ARLZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-272,000	Closed	-$408K	–	435
2018 Q1	$408K	Buy	272,000 +100,000	+58%	+$175K	0.08%	241
2017 Q4	$244K	Hold	172,000	–	–	0.05%	321
2017 Q3	$394K	Buy	+172,000	New	+$230K	0.09%	224
2017 Q2	–	Sell	-66,000	Closed	-$141K	–	379
2017 Q1	$141K	Hold	66,000	–	–	0.04%	307
2016 Q4	$291K	Buy	+66,000	New	+$313K	0.08%	231

Other funds holding ARLZ

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Salzhauer Michael $292M AUM 30% 1-Year Est. Return

PCM

PAR Capital Management Boston, Massachusetts $3.45B AUM 28.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SCP

Silverleafe Capital Partners Germantown, Tennessee $367M AUM 37.49% 1-Year Est. Return

FSA

Franklin Street Advisors Chapel Hill, North Carolina $1.79B AUM 28.1% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Brown Advisory Securities's ARLZ Position: Q2 2018 in Review

Brown Advisory Securities sold out of Aralez Pharmaceuticals Inc. (ARLZ) in Q2 2018, closing a stake of 272,000 shares — an estimated $408K sold.

Brown Advisory Securities first reported a position in ARLZ in Q4 2016 and held it in 5 quarters. The position peaked at $408K in Q1 2018. 48 funds tracked by Wall St. Rank hold ARLZ as of Q2 2018.

Brown Advisory Securities reported no remaining Aralez Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
Brown Advisory Securities sold 272,000 Aralez Pharmaceuticals Inc. shares in Q2 2018, an estimated $408K.
Brown Advisory Securities first reported a position in Aralez Pharmaceuticals Inc. in Q4 2016 and held it in 5 quarters.
Brown Advisory Securities's Aralez Pharmaceuticals Inc. position peaked at $408K in Q1 2018.
48 funds tracked by Wall St. Rank held Aralez Pharmaceuticals Inc. as of Q2 2018.

Based on Brown Advisory Securities's 13F filing for Q2 2018, filed 3 Aug 2018.